Roche’s anemia drug Mircera infringes on Amgen’s patents for its anemia drug Epogen, a jury ruled last year. But maybe Roche should be allowed to sell the drug anyway, and pay a royalty to Amgen.
That’s what Roche has been arguing in federal court, anyway. Amgen says the judge should issue an injunction to keep Mircera [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment